Skip to content

Clinical trials

Observational COVID-19 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Observational Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20203
20217
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Seoul National University Hospital3
Korea University Guro Hospital2
Hanyang University Seoul Hospital1
In Ja Park1
Jaseng Hospital of Korean Medicine1
Keimyung University Dongsan Medical Center1
Kyungpook National University Hospital1
ModernaTX, Inc.1
Seoul National University Bundang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1917
Colorectal Neoplasms1
Coronavirus Infections1
Critical Illness1
Frailty1
Hemolysis1
Kidney Failure, Chronic1
Neoplasms1
Renal Insufficiency, Chronic1
Virus Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.